arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Edwards Lifesciences Corporation

EW Health Care Industrial Specialties
$90.09
▲ +2.0% Today
as of Oct 22, 16:48 ET
Last 30 days +5.34% Sep 14 → Oct 22
$83.77 $85.47 $87.16 $88.86 $90.56 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$88.64
High
$90.18
Low
$88.28
Volume
$3M
Avg Vol
$4M
Mkt Cap
$49.4B
P/E (TTM)
54.81
Beta
—
52w High
$96.29
52w Low
$74.66
Div Yield
—
Shares Out
$577M

Recent Press Releases & News last 60 days · 24 items

lean bull ▲ 4 ● 20 ▼ 0
Oct 22 · 09:15 REGULATORY Medical Device Network bullish
Edwards secures FDA approval for tricuspid valve repair system
Oct 21 · 14:13 MT Newswires neutral
Edwards Lifesciences Gets Approval for Tricuspid Valve Repair System From US FDA
Oct 21 · 13:00 REGULATORY PR Business Wire bullish
FDA Approval of Edwards Lifesciences’ PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve Disease
▸ Show all 24 press releases & news Free account →

EW earnings at a glance

Edwards Lifesciences Corporation (EW) is scheduled to report earnings on Wednesday, November 4, 2026 after the market closes — in 12 days. Analysts expect earnings per share of $0.73, compared with $0.67 in the same quarter last year (+9%). The options market is pricing a move of about ±2.7% after the report, a range of roughly $87.68 to $92.50 from today's $90.09. Over its last 6 reports the stock rose the next day 4 times and fell 2, moving ±3.9% on average; after the most recent report on Jul 23, 2026 it moved -1.4%. That means options currently expect less movement than EW has typically delivered. EW beat the consensus EPS estimate in 5 of its last 6 reported quarters. Implied volatility is currently 23%. The share price of $90.09 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$75
$96
71% of range
Avg surprise (last 6)
+5.4%
Avg reaction (last 6)
+3.0%
67% positive
Latest IV / EM
23%
EM ±2.7% · $85 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.58$1.72$2.85$3.99$5.13 Actual $0.58Actual $0.61Actual $5.13Actual $0.64Est $0.60Actual $0.67Est $0.62Actual $0.67Est $0.59Actual $0.58Est $0.62Actual $0.78Est $0.75Actual $0.78Est $0.73 MarJunSepMar/2025Jun/2025Sep/20258K8KJun/2026
Revenue vs Net Income Revenue Net income
$0$806M$1.6B$2.4B$3.2B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu Jul 23, 2026Jun/2026 $0.78 $0.73 +6.8% +9.0% -1.4% earnings
Thu Apr 23, 20268K 2026-04-23 $0.78 $0.75 +4.0% — +5.6% earnings
Tue Feb 10, 20268K 2026-02-10 $0.58 $0.62 -6.5% — +3.0% earnings
Thu Oct 30, 2025Sep/2025 $0.67 $0.59 +13.6% — -1.2% earnings
Thu Jul 24, 2025Jun/2025 $0.67 $0.62 +8.1% — +5.5% earnings
Wed Apr 23, 2025Mar/2025 $0.64 $0.60 +6.7% — +6.6% earnings
Mon Sep 30, 2024Sep 2024 $5.13 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.61 — — — — financials
Sun Mar 31, 2024Mar 2024 $0.58 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Nov 4, 2026Sep/2026AMC $0.73$0.67 +9.0%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$1.74B$1.65B—$1.55B$1.53B$1.41B—$1.35B
Cost of revenue$392M$363M—$345M$344M$302M—$263M
Gross profit$1.35B$1.29B—$1.21B$1.19B$1.11B—$1.09B
Operating income$513M$478M—$307M$411M$395M—$351M
Net income$242M$381M—$291M$333M$356M—$3.07B
EPS (diluted)$0.42$0.66—$0.50$0.56$0.61—$5.13

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$2.91B$2.45B$2.94B$2.69B$3.27B$3.14B$3.05B$3.68B
Inventory$1.13B$1.12B$1.13B$1.14B$1.14B$1.11B$1.09B$1.10B
Total current assets$6.82B$6.23B$6.74B$6.36B$6.58B$6.21B$6.29B$6.73B
Total assets$13.87B$13.32B$13.70B$13.27B$13.49B$13.02B$13.06B$12.97B
Long-term debt$599M$598M$598M$598M$598M$598M$598M$598M
Total liabilities$3.14B$2.99B$3.36B$3.07B$2.88B$2.83B$2.99B$3.36B
Total equity$10.62B$10.33B$10.34B$10.21B$10.61B$10.19B$10.00B$9.61B

Implied volatility — last 90 days

20%38%57%75%93% Jun 07 — IV 33% · EM ±4.5%Jun 08 — IV 35% · EM ±4.7%Jun 09 — IV 40% · EM ±5.0%Jun 10 — IV 60% · EM ±7.1%Jun 11 — IV 48% · EM ±5.3%Jun 12 — IV 53% · EM ±5.4%Jun 15 — IV 53% · EM ±3.8%Jun 16 — IV 59% · EM ±3.5%Jun 17 — IV 94% · EM ±3.9%Jun 19 — IV 28% · EM ±6.3%Jun 22 — IV 29% · EM ±6.1%Jun 23 — IV 28% · EM ±5.8%Jun 24 — IV 27% · EM ±5.4%Jun 25 — IV 26% · EM ±5.1%Jun 26 — IV 26% · EM ±5.1%Jun 29 — IV 25% · EM ±4.4%Jun 30 — IV 27% · EM ±4.6%Jul 01 — IV 25% · EM ±4.1%Jul 02 — IV 22% · EM ±3.6%Jul 03 — IV 23% · EM ±3.6%Jul 06 — IV 27% · EM ±3.8%Jul 07 — IV 28% · EM ±3.7%Jul 08 — IV 31% · EM ±3.8%Jul 09 — IV 40% · EM ±4.7%Jul 10 — IV 20% · EM ±2.2%Jul 13 — IV 33% · EM ±2.8%Jul 14 — IV 30% · EM ±2.2%Jul 15 — IV 38% · EM ±2.2%Jul 16 — IV 52% · EM ±2.2%Jul 20 — IV 38% · EM ±8.9%Jul 21 — IV 37% · EM ±8.6%Jul 22 — IV 39% · EM ±8.9%Jul 23 — IV 44% · EM ±9.8%Jul 24 — IV 32% · EM ±7.2%Jul 27 — IV 33% · EM ±6.9%Jul 28 — IV 30% · EM ±6.1%Jul 29 — IV 29% · EM ±5.8%Jul 30 — IV 28% · EM ±5.5%Jul 31 — IV 30% · EM ±5.8%Aug 03 — IV 29% · EM ±5.1%Aug 04 — IV 29% · EM ±5.0%Aug 05 — IV 26% · EM ±4.4%Aug 06 — IV 30% · EM ±4.8%Aug 07 — IV 29% · EM ±4.6%Aug 10 — IV 28% · EM ±3.9%Aug 11 — IV 31% · EM ±4.0%Aug 12 — IV 27% · EM ±3.4%Aug 13 — IV 25% · EM ±3.0%Aug 14 — IV 27% · EM ±3.0%Aug 17 — IV 50% · EM ±4.2%Aug 18 — IV 30% · EM ±2.2%Aug 19 — IV 31% · EM ±1.8%Aug 20 — IV 30% · EM ±1.2%Aug 24 — IV 26% · EM ±5.4%Aug 25 — IV 24% · EM ±4.9%Aug 26 — IV 22% · EM ±4.5%Aug 27 — IV 23% · EM ±4.6%Aug 28 — IV 23% · EM ±4.5%Aug 31 — IV 24% · EM ±4.2%Sep 01 — IV 24% · EM ±4.2%Sep 02 — IV 25% · EM ±4.1%Sep 03 — IV 21% · EM ±3.4%Sep 04 — IV 22% · EM ±3.5%Sep 07 — IV 25% · EM ±3.5%Sep 08 — IV 24% · EM ±3.2%Sep 09 — IV 26% · EM ±3.2%Sep 10 — IV 27% · EM ±3.2%Sep 11 — IV 26% · EM ±2.9%Sep 14 — IV 32% · EM ±2.7%Sep 15 — IV 31% · EM ±2.3%Sep 16 — IV 43% · EM ±2.5%Sep 17 — IV 43% · EM ±1.8%Sep 21 — IV 27% · EM ±5.6%Sep 22 — IV 27% · EM ±5.6%Sep 23 — IV 26% · EM ±5.3%Sep 24 — IV 34% · EM ±6.6%Sep 25 — IV 27% · EM ±5.2%Sep 28 — IV 27% · EM ±4.7%Sep 29 — IV 26% · EM ±4.5%Sep 30 — IV 24% · EM ±4.1%Oct 01 — IV 31% · EM ±5.0%Oct 02 — IV 27% · EM ±4.2%Oct 06 — IV 29% · EM ±3.8%Oct 07 — IV 27% · EM ±3.3%Oct 08 — IV 23% · EM ±2.7%

Sector peers

STE
STERIS plc
$20.4B $232.22+3.1%
ZBH
Zimmer Biomet Holdings, Inc.
$16.9B $98.81+2.9%
MAS
Masco Corporation
$13.6B $78.05+4.5%
AIT
Applied Industrial Technologies, Inc.
$12.3B $319.40-3.5%
ALGN
Align Technology, Inc.
$9.9B $155.51+3.3%
MSA
MSA Safety Incorporporated
$6.9B $184.44+1.2%

EW earnings FAQ

When is EW's next earnings date?

Edwards Lifesciences Corporation is expected to report on November 4, 2026, after the market closes.

What is EW's expected move for earnings?

Options currently price a move of about ±2.7%, or $2.41 per share either way from $90.09.

How does EW stock usually react to earnings?

Across the last 6 reports the average next-day move was ±3.9%, up 4 times and down 2 times.

What EPS are analysts expecting from Edwards Lifesciences Corporation?

The consensus estimate is $0.73 per share, versus $0.67 a year ago.

What is EW's implied volatility?

EW's at-the-money implied volatility is about 23% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in